Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma

Title
Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
Authors
Keywords
melanoma, checkpoint blockade, CD8 effector memory T cells, ipilimumab, MDSC
Journal
Oncotarget
Volume 8, Issue 13, Pages -
Publisher
Impact Journals, LLC
Online
2017-02-23
DOI
10.18632/oncotarget.15368

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started